Fenfluramine is a pharmaceutical active ingredient primarily indicated for the treatment of Dravet syndrome and other severe epileptic disorders. It modulates serotonergic signaling, increasing serotonin release and interacting with multiple serotonin receptors to help reduce seizure frequency. Fenfluramine is manufactured under stringent quality standards to ensure high purity and consistency for pharmaceutical formulations.
Mediocon Inc. supplies high-quality Fenfluramine API for pharmaceutical manufacturing and research applications. Our product is manufactured under GMP-compliant conditions and is supported with complete regulatory documentation, including COA, MSDS, TDS, and export documentation.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC Complies |
| Assay (HPLC) | 98.5–101.5% (HPLC) |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.2% |
| Heavy Metals | NMT 20 ppm |
| pH (1% Solution) | 4.5 – 6.5 |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 2.0% |
| Water Content | NMT 1.0% |
| Specific Rotation | Not Applicable |
| Melting Point | 114–118°C |
| Solubility | Freely soluble in water and methanol; soluble in ethanol |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Fenfluramine API Manufacturer & Supplier (CAS 458-24-2) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Fenfluramine API Manufacturer & Supplier is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance